Brief: Sio Gene Therapies Announces Second Quarter Financial Results
10/11/2022 13:27
Nov 10 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* SIO GENE THERAPIES ANNOUNCES FISCAL SECOND QUARTER 2022
FINANCIAL RESULTS
* SIO GENE THERAPIES-STRONG CASH POSITION WITH $49.86
MILLION OF
CASH & CASH EQUIVALENTS AS OF SEPTEMBER 30, EXPECTED TO PROVIDE
CASH RUNWAY BEYOND DEC 2023
* SIO GENE THERAPIES INC - QTRLY LOSS PER SHARE $0.04
Source text for Eikon: ID:nGNX2YyXHx
Further company coverage: SIOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results